Kardium

Diagnostic Equipment · Burnaby, Canada · Founded 2007 · Privately Held (backing)

Developer of medical devices designed to help in the diagnosis and treatment of atrial fibrillation. Kardium is based in Burnaby, Canada and was founded in 2007. It has raised $575 million across 3 recorded rounds; the latest was a $104 million later-stage round in May 2024.

PMV mark · valuation
—
Oct 2026
Priced at
—
Total raised
$575.2M
Last round
Later Stage VC
May 2024
Valuation — not yet established

No valuation for Kardium is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($575.2M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Pro
The prices on Kardium
  • ·8 fund marks: filer, period, implied $/share
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Kardium funding history

3 rounds
DateRoundRaisedPost-money
May 2024Later Stage VC$104.0M▮
Dec 2020Later Stage VC$116.3M▮
Mar 2014Seed Round$269K▮
Unlock post-money valuations

Membership and data by Private Market View

Recent activity

In the last 90 days, Kardium's record added 4 institutional fund marks (latest period Jul 2026).

How much has Kardium raised?

Kardium has raised $575 million in total; 3 of its rounds are on record, from 2014 on. The largest on record was a $269,228 seed round in Mar 2014; the most recent was a $104 million later-stage round in May 2024.

Kardium has filed 3 Form Ds with the SEC since 2010, most recently in Apr 2021 ($116 million sold to 29 investors).

Institutional holders and vehicles

2 SEC-registered funds reported 8 fair-value marks on Kardium between Jun 2026 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.

How Kardium's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Kardium, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →

Frequently asked about Kardium

How much has Kardium raised?
Kardium has raised $575.2M in total funding across 3 recorded rounds.
When did Kardium last raise?
Kardium last raised in May 2024 (Later Stage VC), raising $104.0M.